| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/17/1994 | US5312737 CKS method of HCV protein synthesis |
| 05/17/1994 | US5312736 DNA-sequence encoding the analog; expression vector containing the sequence; transformed or transfected microorganism or cell line comprising the vector; culture preparation of analog; drug including analog |
| 05/17/1994 | US5312735 Supersecreting mutants of saccharomyces cerevisiae |
| 05/17/1994 | US5312734 CDNA encoding a dopamine transporter |
| 05/17/1994 | US5312733 Developmental marker gene of CD4-CD8 thymocytes |
| 05/17/1994 | US5312732 Hormone receptor compositions and methods |
| 05/17/1994 | US5312628 Isolation of a soluble 42 KD pancreatic islet cell autoantigen |
| 05/17/1994 | CA1329681C N_-(1-carboxy-3-phenylpropyl)-l-lysine derivative and process of producing lysinopril using the compound |
| 05/17/1994 | CA1329562C Recombination resistant retroviral helper cell and products produced thereby |
| 05/17/1994 | CA1329561C Potyvirus coat protein genes and plants transformed therewith |
| 05/17/1994 | CA1329542C Plasma and recombinant protein formulations in low ionic strength media |
| 05/14/1994 | CA2102673A1 Expression vectors for bovine trypsin and trypsinogen and host cells transformed therewith |
| 05/11/1994 | WO1994010569A1 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE β-AMYLOID PEPTIDE |
| 05/11/1994 | WO1994010344A1 Diagnostic reagents and their use in the detection of human herpesvirus 7 |
| 05/11/1994 | WO1994010339A1 Evolutive vaccination |
| 05/11/1994 | WO1994010338A1 Nuclear hormone receptor-interacting polypeptides and related molecules and methods |
| 05/11/1994 | WO1994010333A1 Crf binding protein |
| 05/11/1994 | WO1994010330A1 Fibronectin binding protein as well as its preparation |
| 05/11/1994 | WO1994010329A1 Rna packaging system |
| 05/11/1994 | WO1994010323A1 Virus with modified binding moiety specific for the target cells |
| 05/11/1994 | WO1994010322A1 Adenovirus-mediated ldl receptor gene transfer and targeting |
| 05/11/1994 | WO1994010321A1 Turkey herpesvirus vector as a recombinant infectious bursal disease vaccine |
| 05/11/1994 | WO1994010320A1 Plants with reduced susceptibility to plant-parasitic nematodes |
| 05/11/1994 | WO1994010319A1 Process for increasing the protein content of plants |
| 05/11/1994 | WO1994010318A1 Thrombin activatable plasminogen derivatives |
| 05/11/1994 | WO1994010317A2 Conjugate vaccine against group b streptococcus |
| 05/11/1994 | WO1994010316A1 Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof |
| 05/11/1994 | WO1994010315A2 Process for enhancing the content of a selected amino acid in a seed storage protein |
| 05/11/1994 | WO1994010314A1 Allergenic proteins and peptides from johnson grass pollen |
| 05/11/1994 | WO1994010313A2 Interferon tau compositions and methods of use |
| 05/11/1994 | WO1994010312A1 Gene coding for megakaryocyte potentiator |
| 05/11/1994 | WO1994010311A1 The pct-65 serotonin receptor |
| 05/11/1994 | WO1994010310A1 THE St-B17 SEROTONIN RECEPTOR |
| 05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |
| 05/11/1994 | WO1994010308A1 Methods of preparing soluble, oligomeric proteins |
| 05/11/1994 | WO1994010307A1 Transcription factor dp-1 |
| 05/11/1994 | WO1994010306A1 P53 protein fragments and use thereof for detecting and monitoring diseased conditions |
| 05/11/1994 | WO1994010305A1 Transformed endothelial cells |
| 05/11/1994 | WO1994010304A1 Marmoset zona pellucida protein zp3 |
| 05/11/1994 | WO1994010303A1 Multidrug resistance gene |
| 05/11/1994 | WO1994010300A1 Interaction trap system for isolating novel proteins |
| 05/11/1994 | WO1994010294A1 Human monoclonal antibodies to human parvovirus and methods of making and using thereof |
| 05/11/1994 | WO1994010292A1 Biological factors and neural stem cells |
| 05/11/1994 | WO1994010288A2 Medium-chain thioesterases in plants |
| 05/11/1994 | WO1994010207A2 Truncated insulin-like growth factor binding proteins having mitogenic activity |
| 05/11/1994 | WO1994010206A1 Intrinsic inhibitors of aldose reductase |
| 05/11/1994 | WO1994010205A1 Protein specific for alzheimer's disease and method of diagnosing alzheimer's disease through detection of the protein |
| 05/11/1994 | WO1994010204A1 Protein fragments of the pectinatus bacterium |
| 05/11/1994 | WO1994010203A2 Op-3-induced morphogenesis |
| 05/11/1994 | WO1994010202A1 Vascular endothelial cell growth factor antagonists |
| 05/11/1994 | WO1994010201A1 Peptides and vaccines derived from nematode tubulin |
| 05/11/1994 | WO1994010200A1 Somatotropin modifications |
| 05/11/1994 | WO1994010199A1 Expression and purification of cloned human alpha-fetoprotein |
| 05/11/1994 | WO1994010198A1 Method of reducing multidrug resistance in cells and tissues |
| 05/11/1994 | WO1994010197A1 A novel protein tyrosine kinase |
| 05/11/1994 | WO1994010196A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 05/11/1994 | WO1994010195A1 Calcium channel blocking polypeptides from heteropoda venatoria |
| 05/11/1994 | WO1994010194A2 Molecule fragments (peptides) of the main allergens contained in the pollen of trees of the fagales order |
| 05/11/1994 | WO1994010192A1 Process for manufacturing crystals of growth hormone and crystals thereby obtained |
| 05/11/1994 | WO1994010191A1 Low allergenic proteins |
| 05/11/1994 | WO1994010188A1 Activation antigen cd69 |
| 05/11/1994 | WO1994010187A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b) |
| 05/11/1994 | WO1994009879A1 A liquid chromatographic system |
| 05/11/1994 | WO1994009828A1 Dna encoding a human serotonin receptor (5-ht4b) and uses thereof |
| 05/11/1994 | WO1994009824A1 Allergenic extracts |
| 05/11/1994 | WO1994009823A1 Urease-based vaccine against helicobacter infection |
| 05/11/1994 | WO1994009822A1 IMMUNIZATION AGAINST NEISSERIA GONORRHOEAE AND $i(NEISSERIA MENINGITIDIS) |
| 05/11/1994 | WO1994009821A1 Recombinant vaccine for porcine pleuropneumoniae |
| 05/11/1994 | WO1994009820A1 Prostate-specific membrane antigen |
| 05/11/1994 | WO1994009818A1 Method for stimulating production of variable region gene family restricted antibodies through b-cell superantigen vaccination |
| 05/11/1994 | WO1994009815A1 USES OF TGF-β RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT |
| 05/11/1994 | WO1994009814A1 Purified tsh preparation, process for its production and its use for the production of tsh tracers for tsh receptor assays and in tsh receptor assays |
| 05/11/1994 | WO1994009812A1 METHOD FOR PRODUCING LARGE LATENT TRANSFORMING GROWTH FACTOR-β COMPLEXES AND LARGE LATENCY ASSOCIATED PEPTIDE |
| 05/11/1994 | WO1994009811A1 An adhesion molecule |
| 05/11/1994 | WO1994009810A1 Novel biologically active peptides and uses therefor |
| 05/11/1994 | WO1994009808A1 Substances having the growth-promoting effect of amyloid precursor protein |
| 05/11/1994 | WO1994009804A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/11/1994 | WO1994009803A1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 05/11/1994 | WO1994009802A1 Novel bowman-birk inhibitor product for use as an anticarcinogenesis agent |
| 05/11/1994 | WO1994009765A1 Functional interactions between glial s-100b and central nervous system serotonergic neurons |
| 05/11/1994 | WO1994009760A1 Biodegradable polymers for cell transplantation |
| 05/11/1994 | WO1994009651A1 Anti-diarrheic product and method of treating rotavirus-associated infection |
| 05/11/1994 | WO1994009621A1 Mouse deficient in endothelin 1 gene function |
| 05/11/1994 | WO1994003620A3 Method of increasing expression of viral proteins |
| 05/11/1994 | WO1993024641A3 Adeno-associated virus with inverted terminal repeat sequences as promoter |
| 05/11/1994 | EP0596524A2 Hepatocyte growth factor HGF converting protease and gene encoding said protease |
| 05/11/1994 | EP0596508A1 Gene coding for a polypeptide which enhances virus infection of host insects |
| 05/11/1994 | EP0596459A2 Process for purifying recombinant proteins, and use of products thereof |
| 05/11/1994 | EP0596350A1 Cyclopeptides |
| 05/11/1994 | EP0596321A2 Process of unidimensional separation and identification of glycanes, the use of this process for the construction of databanks, the structure characterization of glycans and the relative determination of the Stokes radius of glycanes |
| 05/11/1994 | EP0596034A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage |
| 05/11/1994 | EP0596031A1 Neural calcium-activated neutral proteinase inhibitors |
| 05/11/1994 | EP0596024A1 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 05/11/1994 | EP0595997A1 PROTEIN V: A NOVEL IgG BINDING FACTOR |
| 05/11/1994 | EP0595993A1 Isolation of charged particles from fluids |
| 05/11/1994 | EP0595970A1 Improved vaccine |
| 05/11/1994 | EP0595955A1 Novel type of gram positive replicon and construction of recombinant vectors containing same |
| 05/11/1994 | EP0595948A1 Yeast strains with stable integration of heterologous genes. |
| 05/11/1994 | EP0595935A1 Papilloma virus vaccine |
| 05/11/1994 | EP0595878A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |